Global Sepsis Diagnostics Market Size, Share & Trends Analysis Report by Product Type (Instruments, Assays & Reagents, and Others), By Technology (Molecular Diagnostics, Immunoassay, and Others), By Pathogen (Bacterial Sepsis Diagnostics, Fungal Sepsis Diagnostics, and Others), and Forecast 2019-2025.
The global Sepsis Diagnostics market is estimated to grow significantly during the forecast period. The primary factors that drive the growth of the market include the rising prevalence of sepsis across, rising geriatric population, and the advent of technologically advanced diagnostic solutions. Further, several government initiatives for creating sepsis awareness, and a high incidence of hospital-acquired infections are also likely to propel the sepsis diagnostics market during the forecast period. However, the lack of skilled personnel for handling diagnostics operations may hamper the growth of the market during the forecast period.
The global sepsis diagnostics market is segmented on the basis of product type, technology, and pathogen. Based on the product type, the market is segmented into instruments, assays & reagents, and other products. The assays & reagents segment is estimated to hold a significant share in the market. Based on the technology, the market is segmented into molecular diagnostics, immunoassay, and others including flow cytometry. Whereas, based on the pathogen, the market is segmented into bacterial sepsis diagnostics, fungal sepsis diagnostics, and others. Bacterial sepsis diagnostics is likely to hold a significant share in the market.
Geographically, the study of the global sepsis diagnostics market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global sepsis diagnostics market during the forecast period.
Further, Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are some of the prominent players operating in the global sepsis diagnostics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.
Research Methodology
The market study of the global sepsis diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary Sources Include
The report is intended for pharmaceutical companies, medical device manufacturing companies, industry associations & experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. Global Sepsis Diagnostics Market Research and Analysis by Product Type
2. Global Sepsis Diagnostics Market Research and Analysis by Technology
3. Global Sepsis Diagnostics Market Research and Analysis by Pathogen
The Report Covers
The global Sepsis Diagnostics market is estimated to grow significantly during the forecast period. The primary factors that drive the growth of the market include the rising prevalence of sepsis across, rising geriatric population, and the advent of technologically advanced diagnostic solutions. Further, several government initiatives for creating sepsis awareness, and a high incidence of hospital-acquired infections are also likely to propel the sepsis diagnostics market during the forecast period. However, the lack of skilled personnel for handling diagnostics operations may hamper the growth of the market during the forecast period.
The global sepsis diagnostics market is segmented on the basis of product type, technology, and pathogen. Based on the product type, the market is segmented into instruments, assays & reagents, and other products. The assays & reagents segment is estimated to hold a significant share in the market. Based on the technology, the market is segmented into molecular diagnostics, immunoassay, and others including flow cytometry. Whereas, based on the pathogen, the market is segmented into bacterial sepsis diagnostics, fungal sepsis diagnostics, and others. Bacterial sepsis diagnostics is likely to hold a significant share in the market.
Geographically, the study of the global sepsis diagnostics market report covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), and the Rest of the World. Asia-Pacific is estimated to exhibit a significant growth rate in the global sepsis diagnostics market during the forecast period.
Further, Abbott Laboratories, Inc., Becton, Dickinson & Co., Biomérieux SA, Bruker Corp., Danaher Corp., F. Hoffmann-La Roche Ltd., Luminex Corp., Qiagen NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Trinity Biotech Plc, among others are some of the prominent players operating in the global sepsis diagnostics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market.
Research Methodology
The market study of the global sepsis diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.
Secondary Sources Include
- Financial reports of companies involved in the market
- Whitepapers, research-papers, and news blogs
- Company websites and their product catalog
The report is intended for pharmaceutical companies, medical device manufacturing companies, industry associations & experts, research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. Global Sepsis Diagnostics Market Research and Analysis by Product Type
2. Global Sepsis Diagnostics Market Research and Analysis by Technology
3. Global Sepsis Diagnostics Market Research and Analysis by Pathogen
The Report Covers
- Comprehensive research methodology of the global Sepsis Diagnostics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Sepsis Diagnostics market.
- Insights about market determinants which are stimulating the global Sepsis Diagnostics market.
- Detailed and extensive market segments with regional distribution of forecast revenues.
- Extensive profiles and recent developments of the market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories, Inc.
- Abionic SA
- Accelerate Diagnostics, Inc.
- Becton, Dickinson & Co.
- Biomérieux SA
- Bruker Corp.
- Cepheid Inc.
- Danaher Corp.
- EKF Diagnostics Holdings plc
- F. Hoffmann-La Roche Ltd.
- Immunexpress Inc.
- Inflammatix, Inc.
- Luminex Corp.
- Nanōmix, Inc.
- Qiagen NV
- Quidel Corp.
- Seegene Inc.
- Siemens AG
- Sysmex Corp.
- T2 Biosystems, Inc.
- Thermo Fisher Scientific Inc.
- Trinity Biotech Plc